Clinical Trial Update: Exploratory Study on the Safety, Tolerability, and Pharmacodynamics of IMB-1018972 in Subjects With Angina Due to Obstructive Coronary Artery Disease (IMPROVE-Ischemia) [Phase 2]

View source ↗

Summary

Phase 2 exploratory study assessing safety, tolerability, and pharmacodynamics of IMB-1018972 in patients with angina due to obstructive coronary artery disease…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemia

Drugs mentioned

• IMB-1018972

Snippet

Sponsor: Imbria Pharmaceuticals, Inc. | Conditions: Ischemia, Coronary Artery Disease | Phase 2 | Status: COMPLETED